P013 What's Hot in Pediatric Dermatology
DESCRIPTION
There have been many exciting recent developments in pediatric dermatology. This session will focus on emerging trends and advances in inflammatory, infectious, and neoplastic skin conditions that affect children, with emphasis on diagnostic and treatment strategies including the use of systemic therapies. Updates on management of atopic dermatitis, vitiligo, vascular anomalies, and cutaneous infections in pediatric patients will be provided.
LEARNING OBJECTIVES
Recognize etiologic factors and clinical manifestations of inflammatory, infectious, and neoplastic disorders in pediatric patients and use these observations to formulate state-of-the art management strategies
Utilize recent advances to evaluate and treat atopic dermatitis, vitiligo, vascular anomalies, and cutaneous infections in pediatric patients
SCHEDULE
3:15 PM
Pediatric vitiligo and atopic dermatitis: therapeutic update
Anna Cristina Garza-Mayers, MD, PhD, FAAD
3:40 PM
Q & A
Anna Cristina Garza-Mayers, MD, PhD, FAAD
3:45 PM
What's hot in vascular anomalies
Maria Cecilia Garzon, MD, FAAD
4:10 PM
Q & A
Maria Cecilia Garzon, MD, FAAD
4:15 PM
What's hot in childhood infectious diseases
Mary Elizabeth Larijani, MD, FAAD
4:40 PM
Q & A
Mary Elizabeth Larijani, MD, FAAD
4:45 PM
Rashes in pediatric patients: what's new and what's true
Julie V. Schaffer, MD, FAAD
5:10 PM
Q & A
Julie V. Schaffer, MD, FAAD
DIRECTOR
Julie V. Schaffer, MD, FAAD
Weill-Cornell Medicine
SPEAKERS
Anna Cristina Garza-Mayers, MD, PhD, FAAD
Seattle Children's Hospital, University of Washington
Maria Cecilia Garzon, MD, FAAD
Mary Elizabeth Larijani, MD, FAAD
Perelman School of Medicine at the University of Pennsylvania, Children’s Hospital of Philadelphia
DISCLOSURES
Anna Cristina Garza-Mayers, MD, PhD, FAAD
Incyte – Investigator(No Compensation Received); Sanofi – Investigator(No Compensation Received); Sanofi/Regeneron – Advisory Board(Honoraria);
Maria Cecilia Garzon, MD, FAAD
No financial relationships exist with ineligible companies.
Mary Elizabeth Larijani, MD, FAAD
No financial relationships exist with ineligible companies.
Julie V. Schaffer, MD, FAAD
American Board of Dermatology – Employee(Salary); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights);